FDA works on new strategy to prevent Cronobacter in infant formula

摘要

FDA is developing a strategy to prevent the occurrence of Cronobacter sakazakii in infant formula – a food safety issue that surfaced earlier this year when infant illnesses and deaths caused by Cronobacter triggered a massive recall of Abbott formula and contributed to crippling nationwide shortage.